MP46-12 DECLINES IN SKELETAL MUSCLE MASS AND QUALITY DURING CYTOTOXIC CHEMOTHERAPY PREDICT INCREASED RISK OF CHEMOTHERAPY-ASSOCIATED ADVERSE EVENTS IN MEN WITH TESTIS CANCER. (May 2022) - Phuong, Anthea; Marquardt, J. Peter; Fintelmann, Florian J.; O'Malley, Ryan; Laidlaw, Grace; Eagle, Zachary; Ngo, Steven; Holt, Sarah; Orcutt, Delaney; Schade, George R.; Lin, Daniel W.; Schweizer, Michael T.; et al.